MedPath

PROVE Trial - Positive pRessure therapy in COVid-19 infEction

Phase 3
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2021/04/033175
Lead Sponsor
George Institute for Global Health India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age >= 18 years

2. Laboratory confirmed COVID-19 positive infection

3. Requiring more than 40% oxygen (FiO2 > 0.4) â?? (requiring 6L or more of oxygen by Hudson mask

or nasal cannula) to maintain SpO2 >93%

Exclusion Criteria

1. Obtunded

2. The attending clinician is not committed to patient receiving mechanical ventilatory support

3. In the opinion of the treating clinician the patient is in respiratory distress and is eminently

requiring escalation of treatment including intubation and mechanical ventilation

4. Currently receiving either CPAP, BiPAP, high flow nasal prongs or mechanical ventilation

5. Participants usually on home ventilation (either CPAP or BiPAP)

6. Previous participation in PROVE trial

7. Known or suspected pregnancy

8. Enrolment in the study is not in the best interest of the patient as deemed by the treating clinician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath